Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Ngure

Showing results (201-210 of 234) with videos related to

Pageof 24
Sort By:
AIDS and Behavior|June 9, 2024
Correlates of Adherence to Oral and Vaginal Pre-exposure Prophylaxis (PrEP) Among Adolescent Girls and Young Women (AGYW) Participating in the MTN-034/REACH TrialKenneth Ngure, Erica N Browne, Krishnaveni Reddy, et al.
AIDS (London, England)|October 22, 2019
Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settingsMonica Gandhi, Guohong Wang, Roger King, et al.
PLOS Global Public Health|September 9, 2025
Barriers and facilitators to implementing a single-visit, screen-and-treat approach with thermal ablation for cervical cancer prevention in KenyaHarriet Fridah Adhiambo, Emmah Owidi, Phelix Okello, et al.
Elife|October 25, 2022
Starting to have sexual intercourse is associated with increases in cervicovaginal immune mediators in young women: a prospective study and meta-analysisSean M Hughes, Claire N Levy, Fernanda L Calienes, et al.
Frontiers in Reproductive Health|December 15, 2025
Phone calls to enhance PrEP persistence among Kenyan women accessing postabortal care: a cluster randomized trialRenee Heffron, Lydia Etyang, Bernard Nyerere, et al.
The Lancet. HIV|July 8, 2024
Impact of a point-of-care urine tenofovir assay on adherence to HIV pre-exposure prophylaxis among women in Kenya: a randomised pilot trialMonica Gandhi, David V Glidden, Deepalika Chakravarty, et al.
BMJ Global Health|January 28, 2026
Implementing long-acting injectable HIV pre-exposure prophylaxis services at private pharmacies in Kenya: client, pharmacy provider and key stakeholder perspectives on potential challenges and opportunitiesStephanie D Roche, Kevin Kamolloh, Nicholas Thuo, et al.
The Journal of Infectious Diseases|April 12, 2026
Initiation of oral pre-exposure prophylaxis associated with changes in genital tract T cell phenotypes in women exposed to HIVLakshmi Warrier, Ayumi Saito, Jessica B Graham, et al.
JMIR Research Protocols|March 17, 2023
Correction: A Text Messaging-Based Support Intervention to Enhance Pre-exposure Prophylaxis for HIV Prevention Adherence During Pregnancy and Breastfeeding: Protocol for a Randomized Controlled TrialJerusha Nyabiage Mogaka, Felix Abuna Otieno, Eunita Akim, et al.
JMIR Research Protocols|January 30, 2023
A Text Messaging-Based Support Intervention to Enhance Pre-exposure Prophylaxis for HIV Prevention Adherence During Pregnancy and Breastfeeding: Protocol for a Randomized Controlled TrialJerusha Nyabiage Mogaka, Felix Abuna Otieno, Eunita Akim, et al.
Pageof 24

Showing results (201-210 of 234) with videos related to

Sort By:
Pageof 24
AIDS and Behavior|June 9, 2024
Correlates of Adherence to Oral and Vaginal Pre-exposure Prophylaxis (PrEP) Among Adolescent Girls and Young Women (AGYW) Participating in the MTN-034/REACH TrialKenneth Ngure, Erica N Browne, Krishnaveni Reddy, et al.
AIDS (London, England)|October 22, 2019
Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settingsMonica Gandhi, Guohong Wang, Roger King, et al.
PLOS Global Public Health|September 9, 2025
Barriers and facilitators to implementing a single-visit, screen-and-treat approach with thermal ablation for cervical cancer prevention in KenyaHarriet Fridah Adhiambo, Emmah Owidi, Phelix Okello, et al.
Elife|October 25, 2022
Starting to have sexual intercourse is associated with increases in cervicovaginal immune mediators in young women: a prospective study and meta-analysisSean M Hughes, Claire N Levy, Fernanda L Calienes, et al.
Frontiers in Reproductive Health|December 15, 2025
Phone calls to enhance PrEP persistence among Kenyan women accessing postabortal care: a cluster randomized trialRenee Heffron, Lydia Etyang, Bernard Nyerere, et al.
The Lancet. HIV|July 8, 2024
Impact of a point-of-care urine tenofovir assay on adherence to HIV pre-exposure prophylaxis among women in Kenya: a randomised pilot trialMonica Gandhi, David V Glidden, Deepalika Chakravarty, et al.
BMJ Global Health|January 28, 2026
Implementing long-acting injectable HIV pre-exposure prophylaxis services at private pharmacies in Kenya: client, pharmacy provider and key stakeholder perspectives on potential challenges and opportunitiesStephanie D Roche, Kevin Kamolloh, Nicholas Thuo, et al.
The Journal of Infectious Diseases|April 12, 2026
Initiation of oral pre-exposure prophylaxis associated with changes in genital tract T cell phenotypes in women exposed to HIVLakshmi Warrier, Ayumi Saito, Jessica B Graham, et al.
JMIR Research Protocols|March 17, 2023
Correction: A Text Messaging-Based Support Intervention to Enhance Pre-exposure Prophylaxis for HIV Prevention Adherence During Pregnancy and Breastfeeding: Protocol for a Randomized Controlled TrialJerusha Nyabiage Mogaka, Felix Abuna Otieno, Eunita Akim, et al.
JMIR Research Protocols|January 30, 2023
A Text Messaging-Based Support Intervention to Enhance Pre-exposure Prophylaxis for HIV Prevention Adherence During Pregnancy and Breastfeeding: Protocol for a Randomized Controlled TrialJerusha Nyabiage Mogaka, Felix Abuna Otieno, Eunita Akim, et al.
Pageof 24